Baker Ellis Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Baker Ellis Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	+405	New	+$194K	0.02%	255
2026 Q1	–	Sell	-429	Closed	-$249K	–	270
2025 Q4	$249K	Hold	429	–	–	0.03%	227
2025 Q3	$208K	Buy	+429	New	+$200K	0.03%	236

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baker Ellis Asset Management's TMO Position: Q2 2026 in Review

Baker Ellis Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 405 shares worth $203K. The stake represents 0.02% of the portfolio and ranks #255 among its holdings. This is a return to the name: Baker Ellis Asset Management previously reported a position in TMO as recently as Q4 2025.

Baker Ellis Asset Management first reported a position in TMO in Q3 2025 and has held it in 3 quarters since. The position peaked at $249K in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Baker Ellis Asset Management held 405 shares of Thermo Fisher Scientific worth $203K as of Q2 2026.
Thermo Fisher Scientific was a new Baker Ellis Asset Management position in Q2 2026.
Thermo Fisher Scientific made up 0.02% of Baker Ellis Asset Management's portfolio in Q2 2026, its #255 holding.
Baker Ellis Asset Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 3 quarters since.
Baker Ellis Asset Management's Thermo Fisher Scientific position peaked at $249K in Q4 2025.
2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.